Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1981 1
1982 7
1983 6
1984 4
1985 1
1986 2
1987 1
1988 1
1990 2
1993 1
1995 1
1996 1
1998 3
1999 1
2000 2
2001 1
2002 1
2003 1
2004 2
2005 1
2006 2
2008 1
2009 1
2013 1
2015 1
2017 1
2020 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Diflorasone.
[No authors listed] [No authors listed] 2021 Jan 18. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Jan 18. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000883 Free Books & Documents. Review.
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breas …
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids ma …
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Kaidbey K, Kopper SC, Sefton J, Gibson JR. Kaidbey K, et al. Int J Dermatol. 2001 Jul;40(7):468-71. doi: 10.1046/j.1365-4362.2001.01234.x. Int J Dermatol. 2001. PMID: 11679006 Clinical Trial.
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to each of six sites on their forearms: no treatment, tazarotene vehicle, tazarotene vehicle + tazarotene gel 0.1%, diflorasone diaceta …
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to …
Structures from powders: diflorasone diacetate.
Maccaroni E, Giovenzana GB, Palmisano G, Botta D, Volante P, Masciocchi N. Maccaroni E, et al. Steroids. 2009 Jan;74(1):102-11. doi: 10.1016/j.steroids.2008.09.014. Epub 2008 Oct 18. Steroids. 2009. PMID: 19013475
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment of skin disorders, can be prepared as anhydrous form, DD1 (as deposited in the US pharmacopoeia), or as a monohydrated phase, DDW. ...
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment of skin …
Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
Turi JS, Danielson D, Woltersom JW. Turi JS, et al. J Pharm Sci. 1979 Mar;68(3):275-80. doi: 10.1002/jps.2600680306. J Pharm Sci. 1979. PMID: 423113
Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of drugs applied to skin is discussed. Experimental data are presented for: (a) the flux of diflorasone diacetate through hairless mouse …
Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of d …
Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
Johansson EA, Stiger TR. Johansson EA, et al. Curr Med Res Opin. 1984;9(4):259-64. doi: 10.1185/03007998409109589. Curr Med Res Opin. 1984. PMID: 6510015 Clinical Trial.
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study earlier because of total (100%) improvement of lesions. ...At Week 3, this difference in the improvement of pruritus was marginally significa …
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study e …
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L. Bluefarb SM, et al. J Int Med Res. 1976;4(6):454-61. doi: 10.1177/030006057600400613. J Int Med Res. 1976. PMID: 800385 Free article. Clinical Trial.
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinonide, beta-methasone 17-valerate and fluocinolone acetonide) when the compounds were dissolved in 95% alcohol and applied in vasoconstrictor …
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinon …
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Krueger GG, O'Reilly MA, Weidner M, Dromgoole SH, Killey FP. Krueger GG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):186-90. doi: 10.1016/s0190-9622(98)70238-5. J Am Acad Dermatol. 1998. PMID: 9486672 Clinical Trial.
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. METHODS: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-comparison s …
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diaceta …
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Leibsohn E. Leibsohn E. J Int Med Res. 1982;10(1):22-7. doi: 10.1177/030006058201000104. J Int Med Res. 1982. PMID: 7073809 Free article. Clinical Trial.
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic, were treated with either diflorasone diacetate ointment 0.05% or betamethasone dipropionate ointment 0.05% twice a day for 3 weeks. …
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic …
TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.
Bäumer W, Seegers U, Braun M, Tschernig T, Kietzmann M. Bäumer W, et al. Br J Dermatol. 2004 Oct;151(4):823-30. doi: 10.1111/j.1365-2133.2004.06220.x. Br J Dermatol. 2004. PMID: 15491423
The effects on chemokine concentrations of the highly selective phosphodiesterase 4 inhibitor cilomilast and the glucocorticoid diflorasone diacetate were studied in mouse ears. RESULTS: RANTES and TARC were elevated in both models of allergic contact dermatitis 24 h after …
The effects on chemokine concentrations of the highly selective phosphodiesterase 4 inhibitor cilomilast and the glucocorticoid difloraso …
51 results